← FDA Drug Approvals (Drugs@FDA)

OLANZAPINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALKEM LABS LTD · Approved 2015-10-20

Drug application

FDA Application #

ANDA202295

Application type

Abbreviated New Drug Application (Generic)

Brand name

OLANZAPINE

Generic name

OLANZAPINE

Active ingredients

OLANZAPINE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

ALKEM LABS LTD

Manufacturer

Ascend Laboratories, LLC

First approval

2015-10-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown